Thermal Neutron Relative Biological Effectiveness Factors for Boron Neutron Capture Therapy from In Vitro Irradiations.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
23 09 2020
Historique:
received: 30 07 2020
revised: 20 09 2020
accepted: 21 09 2020
entrez: 26 9 2020
pubmed: 27 9 2020
medline: 14 5 2021
Statut: epublish

Résumé

The experimental determination of the relative biological effectiveness of thermal neutron factors is fundamental in Boron Neutron Capture Therapy. The present values have been obtained while using mixed beams that consist of both neutrons and photons of various energies. A common weighting factor has been used for both thermal and fast neutron doses, although such an approach has been questioned. At the nuclear reactor of the Institut Laue-Langevin a pure low-energy neutron beam has been used to determine thermal neutron relative biological effectiveness factors. Different cancer cell lines, which correspond to glioblastoma, melanoma, and head and neck squamous cell carcinoma, and non-tumor cell lines (lung fibroblast and embryonic kidney), have been irradiated while using an experimental arrangement designed to minimize neutron-induced secondary gamma radiation. Additionally, the cells were irradiated with photons at a medical linear accelerator, providing reference data for comparison with that from neutron irradiation. The survival and proliferation were studied after irradiation, yielding the Relative Biological Effectiveness that corresponds to the damage of thermal neutrons for the different tissue types.

Identifiants

pubmed: 32977400
pii: cells9102144
doi: 10.3390/cells9102144
pmc: PMC7598166
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Neurooncol. 2003 Mar-Apr;62(1-2):123-34
pubmed: 12749708
Int J Radiat Biol. 2011 Dec;87(12):1162-72
pubmed: 21923301
Radiat Oncol. 2017 Aug 15;12(1):130
pubmed: 28806981
Appl Radiat Isot. 2020 Mar;157:109018
pubmed: 31889683
Radiat Res. 1984 May;98(2):307-16
pubmed: 6729040
Radiother Oncol. 1990 Jun;18(2):165-81
pubmed: 2367691
Radiat Oncol. 2012 Aug 29;7:146
pubmed: 22929110
Appl Radiat Isot. 2004 Nov;61(5):1021-6
pubmed: 15308186
Sci Rep. 2018 Jan 17;8(1):988
pubmed: 29343841
Int J Radiat Oncol Biol Phys. 1993 Dec 1;27(5):1121-9
pubmed: 8262837
Radiat Res. 1975 Nov;64(2):245-55
pubmed: 1197637
Sci Rep. 2019 Jul 12;9(1):10132
pubmed: 31300704
J Neurooncol. 1997 May;33(1-2):71-80
pubmed: 9151225
Br J Radiol. 2003 Mar;76(903):163-76
pubmed: 12684232
Rep Pract Oncol Radiother. 2016 Mar-Apr;21(2):95-101
pubmed: 26933390
J Appl Clin Med Phys. 2016 Jan 08;17(1):179-191
pubmed: 26894351
Radiat Res. 2012 Dec;178(6):609-21
pubmed: 23148506
Med Phys. 2002 Feb;29(2):145-56
pubmed: 11865986

Auteurs

María Pedrosa-Rivera (M)

Departamento de Física Atómica, Molecular y Nuclear, Facultad de Ciencias, Universidad de Granada, 18071 Granada, Spain.

Javier Praena (J)

Departamento de Física Atómica, Molecular y Nuclear, Facultad de Ciencias, Universidad de Granada, 18071 Granada, Spain.

Ignacio Porras (I)

Departamento de Física Atómica, Molecular y Nuclear, Facultad de Ciencias, Universidad de Granada, 18071 Granada, Spain.

Manuel P Sabariego (MP)

Departamento de Física Atómica, Molecular y Nuclear, Facultad de Ciencias, Universidad de Granada, 18071 Granada, Spain.

Ulli Köster (U)

Institut Laue-Langevin, 71 Avenue des Martyrs, CEDEX 9, 38042 Grenoble, France.

Michael Haertlein (M)

Institut Laue-Langevin, 71 Avenue des Martyrs, CEDEX 9, 38042 Grenoble, France.
Partnership for Structural Biology (PSB), CEDEX 9, 38042 Grenoble, France.

V Trevor Forsyth (VT)

Institut Laue-Langevin, 71 Avenue des Martyrs, CEDEX 9, 38042 Grenoble, France.
Partnership for Structural Biology (PSB), CEDEX 9, 38042 Grenoble, France.
Faculty of Natural Sciences, Keele University, Staffordshire ST5 5BG, UK.

José C Ramírez (JC)

Servicio de Radiofísica y Protección Radiológica, Hospital Universitario Virgen de las Nieves, Avda. Fuerzas Armadas 2, 18014 Granada, Spain.

Clara Jover (C)

Servicio de Radiofísica y Protección Radiológica, Hospital Universitario Virgen de las Nieves, Avda. Fuerzas Armadas 2, 18014 Granada, Spain.

Daniel Jimena (D)

Servicio de Radiofísica y Protección Radiológica, Hospital Universitario Virgen de las Nieves, Avda. Fuerzas Armadas 2, 18014 Granada, Spain.

Juan L Osorio (JL)

Servicio de Radiofísica y Protección Radiológica, Hospital Universitario Virgen de las Nieves, Avda. Fuerzas Armadas 2, 18014 Granada, Spain.

Patricia Álvarez (P)

Departamento de Bioquímica y Biología Molecular III e Inmunología, Facultad de Medicina, Universidad de Granada, 18016 Granada, Spain.

Carmen Ruiz-Ruiz (C)

Departamento de Bioquímica y Biología Molecular III e Inmunología, Facultad de Medicina, Universidad de Granada, 18016 Granada, Spain.

María J Ruiz-Magaña (MJ)

Departamento de Bioquímica y Biología Molecular III e Inmunología, Facultad de Medicina, Universidad de Granada, 18016 Granada, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH